Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Miscellaneous and site unspecified neoplasms malignant and unspecified
ADR ID BADD_A02790
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10027655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01803Porfimer sodium--
BADD_D01804Posaconazole--
BADD_D01814Pralatrexate0.002518%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01822Prasugrel--
BADD_D01823Prasugrel hydrochloride--
BADD_D01831Prednisolone0.000297%
BADD_D01834Prednisone0.000090%
BADD_D01835Pregabalin0.002256%
BADD_D01846Procarbazine0.000806%
BADD_D01847Procarbazine hydrochloride--
BADD_D01852Progesterone--
BADD_D01856Propafenone0.000418%
BADD_D01858Propagermanium--
BADD_D01867Propranolol0.000053%
BADD_D01888Quetiapine--
BADD_D01892Quinaprilat0.001813%
BADD_D01898Rabeprazole--
BADD_D01901Radium--
BADD_D01903Raloxifene--
BADD_D01905Raltegravir0.004944%
BADD_D01906Raltegravir potassium--
BADD_D01909Ramipril0.000420%
BADD_D01913Ranitidine0.002526%
BADD_D01915Ranolazine0.000996%
BADD_D01916Rasagiline mesylate--
BADD_D01922Regorafenib0.000504%
BADD_D01927Reslizumab--
BADD_D01933Ribavirin0.011868%
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 18 Pages